FMR1 Repeat Expansion Testing

Description
Pathogenic CGG repeat expansions in the FMR1 gene have been associated with X-linked fragile X syndrome (FXS), manifested primarily and more severely in males. Premutation alleles have been associated with increased risk for Fragile X-associated tremor/ataxia syndrome (FXTAS). Full expansion alleles are associated with aberrant hypermethylation of the CGG expansion resulting in the decrease or silencing of FMR1 transcription and the subsequent loss of encoded FMRP protein. The absence of FMRP appears to disrupt neurotransmission mediated by the metabotropic glutamate receptor (mGluR). Premutation alleles, on the other hand, are thought to cause increased levels of FMR1 mRNA which can form toxic inclusions 1.
Pathogenicity is dependent upon CGG repeat length according to the following ranges 2-4:
Normal Alleles | Mutable Normal Alleles | Intermediate/Uncertain Alleles | Premutation Alleles | Full Penetrance Alleles |
5-44 | - | 45-54 | 55-200* | 201 or more |
*Females with premutation alleles are at increased risk of having children with FXS.
Tests That Analyze FMR1 Repeats
- Genomic Unity® 2.0
- Genomic Unity® Whole Genome Analysis
- Genomic Unity® Lightning Genome Analysis – Neonatal
- Genomic Unity® Lightning Genome Analysis – Pediatric
- Genomic Unity® Lightning Genome Analysis – Standard
- Genomic Unity® Exome Plus Analysis
- Genomic Unity® Exome Analysis
- Genomic Unity® Genome-Wide CNV and FMR1 Analysis
- Genomic Unity® Movement Disorders Analysis
- Genomic Unity® Comprehensive Ataxia Analysis
- Genomic Unity® Ataxia Repeat Expansion Analysis
- Genomic Unity® Epilepsy Analysis
- Genomic Unity® X-Linked Intellectual Disability Plus Analysis
- IriSight® Comprehensive Analysis – Prenatal
- Genomic Inform®